Legend Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
ClinChoice operates a network of investigator sites that participate in clinical studies to support drug and device development.
BiotechHealthtechMedical DevicesPhiladelphia, US
Dr. John Balian(CEO)
PartnerFrank Hong· solo GP
Co-investorsDFJ DragonFundDraper AssociatesDraper DragonApricot CapitalLilly Asia VenturesSherpa Healthcare Partners
Eswin manufactures 12-inch electronic-grade silicon wafers and epitaxial wafers for semiconductors used in storage chips, logic chips, image sensors, display driver chips, and power devices in communications and electric vehicle applications.
Advanced ManufacturingAI & Machine LearningHardwareIoTNew MaterialsSemiconductorsBeijing, CN
Wang Dongsheng(Chairman)
PartnerFrank Hong· solo GP
Co-investorsSource Code CapitalChina Internet Investment FundIDG CapitalShang Qi Capital
Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter.
HardwareHealthtechMedical DevicesShanghai, CN
Co-investorsB Capital GroupB4 Capital
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.